Skip to Content
Merck
  • High-efficiency non-mosaic CRISPR-mediated knock-in and indel mutation in F0 Xenopus.

High-efficiency non-mosaic CRISPR-mediated knock-in and indel mutation in F0 Xenopus.

Development (Cambridge, England) (2017-07-12)
Yetki Aslan, Emmanuel Tadjuidje, Aaron M Zorn, Sang-Wook Cha
ABSTRACT

The revolution in CRISPR-mediated genome editing has enabled the mutation and insertion of virtually any DNA sequence, particularly in cell culture where selection can be used to recover relatively rare homologous recombination events. The efficient use of this technology in animal models still presents a number of challenges, including the time to establish mutant lines, mosaic gene editing in founder animals, and low homologous recombination rates. Here we report a method for CRISPR-mediated genome editing in Xenopus oocytes with homology-directed repair (HDR) that provides efficient non-mosaic targeted insertion of small DNA fragments (40-50 nucleotides) in 4.4-25.7% of F0 tadpoles, with germline transmission. For both CRISPR/Cas9-mediated HDR gene editing and indel mutation, the gene-edited F0 embryos are uniformly heterozygous, consistent with a mutation in only the maternal genome. In addition to efficient tagging of proteins in vivo, this HDR methodology will allow researchers to create patient-specific mutations for human disease modeling in Xenopus.

MATERIALS
Product Number
Brand
Product Description

Roche
Anti-HA-Biotin, High Affinity (3F10), from rat IgG1
Sigma-Aldrich
Monoclonal ANTI-FLAG® M2 antibody produced in mouse, clone M2, purified immunoglobulin (Purified IgG1 subclass), buffered aqueous solution (10 mM sodium phosphate, 150 mM NaCl, pH 7.4, containing 0.02% sodium azide)